Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival bevacizumab vs mitomycin in Ahmed Glaucoma Valve surgery
IRCT20210521051355N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab and mitomycin c in Glaucoma (2 arms), sponsored by Iran University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
bevacizumabmitomycin c
03
Conditions
Glaucoma
Beyond the preview
Go deeper on IRCT20210521051355N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210521051355N1.